Those who showed ‘sub-optimal’ response to cholesterol-lowering drugs also 22% more likely to develop heart disease
Around half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, new research suggests.
Guidelines from the National Institute for Health and Care Excellence (Nice) aim for a 40% or more reduction in low density lipoprotein cholesterol from the treatment.
Continue reading...from The Guardian http://bit.ly/2Izic1h
